Defibrillation Thresholds in Hypertrophic Cardiomyopathy

Abstract

Patients with HCM do not have elevated DFTs as compared to more typical populations undergoing implantable cardioverter-defibrillator implant; high-energy devices or complex lead systems are not needed routinely in this population.